Literature DB >> 10605821

Role of polyamines in mediating malignant transformation and oncogene expression.

A Tabib1, U Bachrach.   

Abstract

Previous studies have demonstrated that polyamines accumulate in cancer cells and that overproduction of ornithine decarboxylase (ODC), which catalyzes polyamine synthesis, elicits the acquisition of the transformed phenotype. However, it was not clear whether the expression of ODC and the accumulation of polyamines are only innocent by-products of the transformation process. In this study we confirm previous findings what polyamines can trigger the transformation of immortalized cultured cells. In addition to NIH 3T3 fibroblasts, studied previously, rat kidney epithelial cells or fibroblasts also grew in soft agar in the presence of polyamines. It has also been demonstrated that spermidine, preferentially stimulated the transcription and the expression of c-myc while those of c-fos were preferentially stimulated by putrescine. These findings suggest that the effect of polyamines on cellular transformation, could be explained, at least partially, by stimulation of proto-oncogene expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10605821     DOI: 10.1016/s1357-2725(99)00098-9

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  13 in total

Review 1.  DFMO: targeted risk reduction therapy for colorectal neoplasia.

Authors:  Christina M Laukaitis; Eugene W Gerner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-08       Impact factor: 3.043

2.  Leishmania donovani polyamine biosynthetic enzyme overproducers as tools to investigate the mode of action of cytotoxic polyamine analogs.

Authors:  Sigrid C Roberts; Yuqui Jiang; Judith Gasteier; Benjamin Frydman; Laurence J Marton; Olle Heby; Buddy Ullman
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  Polyamine metabolism is sensitive to glycolysis inhibition in human neuroblastoma cells.

Authors:  M Victoria Ruiz-Pérez; Miguel Ángel Medina; José Luis Urdiales; Tuomo A Keinänen; Francisca Sánchez-Jiménez
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

4.  A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma.

Authors:  Yujie Shen; Qiang Huang; Yifan Zhang; Chi-Yao Hsueh; Liang Zhou
Journal:  Cancer Cell Int       Date:  2022-07-08       Impact factor: 6.429

5.  Effect of spermine synthase on the sensitivity of cells to anti-tumour agents.

Authors:  Yoshihiko Ikeguchi; Caroline A Mackintosh; Diane E McCloskey; Anthony E Pegg
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

6.  Expression of ornithine decarboxylase in precancerous and cancerous gastric lesions.

Authors:  Xin-Pu Miao; Jian-Sheng Li; Hui-Yan Li; Shi-Ping Zeng; Ye Zhao; Jiang-Zheng Zeng
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

7.  K-FGF mediated transformation and induction of metastatic potential involves altered ornithine decarboxylase and S-adenosylmethionine decarboxylase expression--role in cellular invasion.

Authors:  Marcus S Hardin; Rene Mader; Robert A R Hurta
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

8.  Subcutaneous Toxicity of Agmatine in Rats.

Authors:  Tayfun Uzbay; Fatma Duygu Kaya Yertutanol; Ahmet Midi; Burcu Çevreli
Journal:  Turk J Pharm Sci       Date:  2017-08-15

9.  Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform.

Authors:  Ramesh Ummanni; Frederike Mundt; Heike Pospisil; Simone Venz; Christian Scharf; Christine Barett; Maria Fälth; Jens Köllermann; Reinhard Walther; Thorsten Schlomm; Guido Sauter; Carsten Bokemeyer; Holger Sültmann; A Schuppert; Tim H Brümmendorf; Stefan Balabanov
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

10.  Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas.

Authors:  K P Raj; J A Zell; C L Rock; C E McLaren; C Zoumas-Morse; E W Gerner; F L Meyskens
Journal:  Br J Cancer       Date:  2013-01-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.